泌尿系统手术器械市场－全球产业规模、份额、趋势、机会及预测（依产品、应用、区域及竞争格局划分，2021-2031年）

全球泌尿系统手术器械市场预计将从 2025 年的 119.8 亿美元成长到 2031 年的 189.3 亿美元，复合年增长率达到 7.92%。

此细分市场包括用于诊断和治疗泌尿系统和男性生殖器官疾病的专用医疗设备，例如内视镜、雷射系统、体外碎石机和机器人平台。推动该市场发展的关键因素包括全球人口快速老化以及泌尿器官系统恶性肿瘤和慢性肾臟病率的上升，这些疾病需要频繁的手术治疗。例如，美国癌症协会估计，到2025年，美国将新增313,780例前列腺癌病例，凸显了对精密手术器械的迫切需求，以应对这一重大的健康问题。

儘管市场呈现积极的成长趋势，但由于操作复杂设备的熟练专业人员短缺，该市场仍面临许多挑战。人才短缺限制了可进行的手术数量，进而阻碍了新设备的普及，尤其是在医疗资源匮乏的地区。美国泌尿系统协会2025年的数据显示，美国62%的县都面临泌尿系统短缺的问题，凸显了严重的资源分配问题，这些问题限制了手术能力，并阻碍了市场的整体扩张。

市场驱动因素

机器人和雷射手术技术的进步，透过提高手术精度和缩短患者復原时间，成为推动市场成长的主要催化剂。这些创新使得微创技术成为临床实践的优先选择，使外科医生能够更有效率、更少地进行切除术和肾切除併发症等复杂手术。机器人平台与高清成像和关节活动功能的集成，正促使医院采用这些设备以提供更高标准的医疗服务。这一转变也体现在手术数据中。在2024年1月的新闻稿中，直觉外科公司（Intuitive Surgical）报告称，2023年全球达文西手术量较2022年增长约22%，显示机器人手术在泌尿系统领域的应用正在迅速扩展。

此外，泌尿系统疾病和慢性肾臟病（CKD）发病率的上升也推动了对专用诊断和手术器械的需求。随着肾结石、尿失禁和肾衰竭等疾病负担的加重，内视镜、体外碎石机和透析相关设备的需求也随之增长。英国肾臟护理协会（Renal Care UK）在2024年5月的一篇报导中指出，英国估计有720万人患有1-5期慢性肾臟病，这是大规模的患者群体，需要长期的泌尿系统护理。这种疾病负担转化为製造商的利润成长。波士顿科学公司（Boston Scientific）在2024年报告称，其泌尿系统业务在2023年实现了19.64亿美元的净销售额，同比增长10.8%，这主要得益于其结石治疗产品线的强劲表现。

市场挑战

合格的泌尿系统医疗设备操作人员短缺是市场扩张的一大障碍。由于这些手术器械需要训练有素的专业人员才能安全操作，因此目前医疗专业人员的数量无法满足手术需求。当医疗机构缺乏进行专业手术所需的人员时，它们就不愿意投资额外的设备，这直接导致采购量下降和存货周转减慢。因此，儘管患者需求不断增长，但人员短缺有效地限制了潜在市场规模。

泌尿系统领域本身的人口结构变化而进一步加剧。根据美国泌尿系统协会统计，到2024年，美国约有30%的泌尿系统将超过65岁，这预示着即将到来的退休潮可能会进一步扩大现有的人才缺口。因此，泌尿系统人员配备不足限制了手术频率，进而抑制了医疗器材的普及，并降低了医疗设备製造商的收入潜力。

市场趋势

随着医疗机构日益重视感染控制和营运效率，抛弃式输尿管镜和膀胱镜的快速普及正在改变其筹资策略。与需要耗费大量成本和时间进行再处理的传统可重复使用器械不同，一次性器械消除了交叉感染的风险，并确保性能稳定可靠，无需维护。这种转变在高流量医疗机构尤其显着，因为消毒延迟会降低手术效率，迫使医院选择无菌替代方案。这种普及带来的财务影响显而易见。 2025年1月，Ambu A/S公司报告称，其泌尿系统、耳鼻喉科和胃肠病业务部门实现了23.9%的有机收入增长，这主要得益于市场对一次性输尿管镜解决方案的持续需求。

此外，具备即时连接功能的智慧手术器械的开发，标誌着传统机器人辅助技术的重大革新。製造商正将先进的运算能力和感测技术融入下一代平台，为外科医生提供触觉回馈和可操作的洞察，超越了纯机械远端操控设备的能力。这些智慧系统利用数据优化临床工作流程，并提供先进的模拟训练，从而提升外科医生的技能和决策能力。市场已迅速接受这些先进平台。在2025年1月举行的摩根大通医疗保健大会上，直觉外科公司透露，自其最新达文西5系统上市以来，已向客户交付了362套。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球泌尿系统手术器械市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（内视镜、Envision系统、周边设备、配件/耗材、其他）
  • 依应用领域（慢性肾臟病、良性摄护腺增生 (BPH)、尿道结石、尿失禁 (UI) 和骨盆器官脱垂(POP)、肿瘤、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美泌尿系统手术器械市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲泌尿系统手术器械市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区泌尿系统手术器械市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲泌尿系统手术器械市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲泌尿系统手术器械市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球泌尿系统手术器械市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic plc
• Boston scientific corporation
• Karl Storz GmbH & Co. KG
• Cook Medical Inc
• Richard Wolf GmbH
• Teleflex Incorporated
• Coloplast Corp.
• CONMED Corporation
• CR Bard Inc.
• Olympus Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Urology Surgical Instruments Market is projected to expand from USD 11.98 Billion in 2025 to USD 18.93 Billion by 2031, achieving a compound annual growth rate of 7.92%. This sector comprises a specialized range of medical devices, such as endoscopes, laser systems, lithotripters, and robotic platforms, all engineered for diagnosing and treating conditions of the urinary tract and male reproductive organs. The primary factors driving this market include a rapidly aging global population and increasing rates of urological malignancies and chronic kidney diseases, which demand frequent surgical care. For instance, the American Cancer Society estimates that there will be 313,780 new cases of prostate cancer in the United States in 2025, emphasizing the urgent need for precise surgical tools to address this significant health burden.

Despite these positive growth trends, the market faces a substantial obstacle due to a shortage of skilled specialists needed to operate these complex instruments. This gap in the workforce restricts the number of procedures that can be carried out, especially in underserved areas, which in turn limits the adoption of new equipment. Data from the American Urological Association in 2025 revealed that 62% of counties in the United States lack a practicing urologist, highlighting a severe distribution issue that constrains procedural capacity and hampers broader market expansion.

Market Driver

Technological progress in robotic-assisted and laser surgery serves as a key catalyst for market growth by improving surgical precision and shortening patient recovery times. These innovations have led to a clinical preference for minimally invasive techniques, enabling surgeons to perform complex operations like prostatectomies and nephrectomies with greater efficacy and fewer intraoperative complications. The integration of high-definition imaging and articulation in robotic platforms encourages hospitals to adopt this equipment to provide superior standards of care. This shift is reflected in procedural data; Intuitive Surgical reported in its January 2024 press release that worldwide da Vinci procedures increased by approximately 22% in 2023 compared to 2022, demonstrating the rapid growth of robotic usage in urology.

Furthermore, the rising incidence of urological disorders and chronic kidney diseases (CKD) fuels the demand for specialized diagnostic and surgical tools. As the burden of conditions such as kidney stones, urinary incontinence, and renal failure grows, there is a corresponding need for endoscopes, lithotripters, and dialysis-related devices. Kidney Care UK noted in a May 2024 article that an estimated 7.2 million people in the United Kingdom suffer from chronic kidney disease stages 1-5, representing a large patient population requiring long-term urological care. This disease burden translates into financial growth for manufacturers; Boston Scientific reported in 2024 that its Urology business generated net sales of $1.964 billion in 2023, a 10.8% increase driven by strong results in its stone management portfolio.

Market Challenge

The shortage of qualified specialists capable of operating complex urological devices creates a significant barrier to market advancement. Because these surgical instruments require highly trained professionals for safe operation, the current workforce struggles to keep up with the demand for procedures. When healthcare facilities lack the necessary personnel to perform specialized interventions, they are less likely to invest in additional equipment, which directly reduces procurement volumes and slows inventory turnover. Consequently, this workforce constraint effectively caps the total addressable market, regardless of the rising needs of patients.

This labor shortage is further aggravated by demographic shifts within the medical specialty itself. According to the American Urological Association, approximately 30 percent of practicing urologists in the United States were aged 65 years or older in 2024, indicating an approaching wave of retirements that threatens to widen the existing supply gap. As a result, the inability to fully staff urology departments limits the frequency of surgical procedures, thereby restricting the adoption rate of instrumentation and diminishing revenue potential for device manufacturers.

Market Trends

The rapid shift toward Single-Use Disposable Ureteroscopes and Cystoscopes is transforming procurement strategies as healthcare providers focus on infection control and operational efficiency. Unlike traditional reusable devices that demand expensive and time-consuming reprocessing, single-use instruments eliminate the risk of cross-contamination and ensure consistent performance without maintenance delays. This transition is especially prevalent in high-volume settings where sterilization lags can slow down procedural throughput, pushing hospitals to choose sterile alternatives. The financial impact of this adoption is evident; Ambu A/S reported in January 2025 that its Urology, ENT, and GI business group achieved 23.9% organic revenue growth, driven largely by sustained demand for its disposable ureteroscopy solutions.

Additionally, the development of Smart Surgical Instruments with Real-Time Connectivity marks a significant evolution beyond standard robotic assistance. Manufacturers are now embedding substantial computing power and sensing technologies into next-generation platforms to provide surgeons with haptic feedback and actionable insights, exceeding the capabilities of purely mechanical tele-manipulators. These intelligent systems use data to optimize clinical workflows and offer advanced simulation training, thereby enhancing surgeon proficiency and decision-making. The market has quickly embraced these sophisticated platforms; Intuitive Surgical revealed in a January 2025 presentation at the J.P. Morgan Healthcare Conference that 362 units of its latest da Vinci 5 system had been placed with customers since its commercial launch.

Key Market Players

• Medtronic plc
• Boston scientific corporation
• Karl Storz GmbH & Co. KG
• Cook Medical Inc
• Richard Wolf GmbH
• Teleflex Incorporated
• Coloplast Corp.
• CONMED Corporation
• C. R. Bard Inc.
• Olympus Corporation

Report Scope

In this report, the Global Urology Surgical Instruments Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Urology Surgical Instruments Market, By Product

• Endoscopes
• Envision Systems
• Peripheral Systems
• Accessories & Consumables
• Others

Urology Surgical Instruments Market, By Application

• Chronic Kidney Disease
• Benign Prostatic Hyperplasia (BPH)
• Urinary Stones
• Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)
• Oncology
• Others

Urology Surgical Instruments Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Urology Surgical Instruments Market.

Available Customizations:

Global Urology Surgical Instruments Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Urology Surgical Instruments Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Endoscopes, Envision Systems, Peripheral Systems, Accessories & Consumables, Others)
  • 5.2.2. By Application (Chronic Kidney Disease, Benign Prostatic Hyperplasia (BPH), Urinary Stones, Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP), Oncology, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Urology Surgical Instruments Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Urology Surgical Instruments Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Urology Surgical Instruments Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Urology Surgical Instruments Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Urology Surgical Instruments Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Urology Surgical Instruments Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. France Urology Surgical Instruments Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Urology Surgical Instruments Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Urology Surgical Instruments Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Urology Surgical Instruments Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia Pacific Urology Surgical Instruments Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Urology Surgical Instruments Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Urology Surgical Instruments Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Urology Surgical Instruments Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Urology Surgical Instruments Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Urology Surgical Instruments Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. Middle East & Africa Urology Surgical Instruments Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Urology Surgical Instruments Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Urology Surgical Instruments Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Urology Surgical Instruments Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. South America Urology Surgical Instruments Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Urology Surgical Instruments Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Urology Surgical Instruments Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Urology Surgical Instruments Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Urology Surgical Instruments Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boston scientific corporation
• 15.3. Karl Storz GmbH & Co. KG
• 15.4. Cook Medical Inc
• 15.5. Richard Wolf GmbH
• 15.6. Teleflex Incorporated
• 15.7. Coloplast Corp.
• 15.8. CONMED Corporation
• 15.9. C. R. Bard Inc.
• 15.10. Olympus Corporation

16. Strategic Recommendations

17. About Us & Disclaimer